Stocktoria
ORAMED PHARMACEUTICALS INC. ORMP
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2002-04-01
ORAMED PHARMACEUTICALS INC. insider transactions (Form 4)
| Insider | Role | Date | Action | Shares | Price |
|---|---|---|---|---|---|
| KIDRON NADAV | President and CEO | 2026-03-30 | Tax withheld | 44,818 | $3.31 |
| Kidron Miriam | Chief Scientific Officer | 2026-03-30 | Tax withheld | 435,084 | $3.31 |
| Kidron Miriam | Chief Scientific Officer | 2026-03-17 | Grant | 119,558 | — |
| KIDRON NADAV | President and CEO | 2026-03-17 | Grant | 167,005 | — |
| Hexter Joshua | COO & CBO | 2026-03-17 | Grant | 95,889 | — |
| Gabay Avraham | Chief Financial Officer | 2026-03-17 | Grant | 95,889 | — |
| KIDRON NADAV | President and CEO | 2026-03-12 | Gift | 100,000 | — |
| Hexter Joshua | COO & CBO | 2026-01-22 | Option exercise | 19,000 | — |
Source: SEC EDGAR filings · CIK 0001176309 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.